Topics

Companies Related to "RECORDATI ACQUIRE WORLDWIDE RIGHTS SIGNIFOR OSILODROSTAT LCI699" [Most Relevant Company Matches] RSS

03:47 EDT 24th August 2019 | BioPortfolio

Here are the most relevant search results for "RECORDATI ACQUIRE WORLDWIDE RIGHTS SIGNIFOR OSILODROSTAT LCI699" found in our extensive corporate database of over 50,000 company records.

Showing "RECORDATI ACQUIRE WORLDWIDE RIGHTS SIGNIFOR OSILODROSTAT LCI699" Companies 1–25 of 3,400+

Relevant

Recordati Rare Diseases Canada Inc.

Recordati Rare Diseases Canada Inc. is a biopharmaceutical company committed to providing often overlooked orphan therapies to underserved rare disease communities in Canada. Recordati Rare Diseases Canada Inc. and our sister company, Orphan Europe, are part of the rare disease business within the Recordati Group, a public global pharmaceutical company co...


RECORDATI CORPORATION

Recordati, established in 1926, is a European pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), dedicated to the research, development, manufacturing and marketing of pharmaceuticals, with headquarters in Milan, Italy, operations in the main European countries, and a total staff of over 2,000. A European field force of over 1,000 me...

Unigene Laboratories, Inc.

Unigene Laboratories, Inc. is a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs. Due to the size of the worldwide osteoporosis market, Unigene is targeting its initial efforts on developing calcitonin and PTH-based therapies. Fortical®, Unigene's nasal calcitonin product for the treatment of postmenopausal...


Cavit Sciences

Cavit Sciences, Inc. (“Cavit”) is a biotechnology company engaged in developing treatments of cancer and viral infections. Our strategy is to develop and commercialize intellectual property rights to treat, prevent and inhibit several major diseases including cancers, viral infections and diseases associated with cancers and viral infections. We currently own three patent applicati...

MPEG LA, LLC

MPEG LA is the world leader in alternative technology licenses, enabling users to acquire worldwide patent rights necessary for a technology standard or platform from multiple patent owners in a single transaction as an alternative to negotiating individual licenses. Wherever an independently administered one-stop patent license would provide a convenient ...

Coalition to Protect Patients’ Rights

The Coalition to Protect Patients’ Rights is a non-partisan, grassroots coalition made up of over 10,000 doctors, healthcare providers, advocacy groups, and concerned citizens who are dedicated to the implementation of patient-centered healthcare reform that will improve patient care. For more information, visit the Coalition to Protect Patients’...

Jericho Systems Corporation and Patient Privacy Rights

Patient Privacy Rights is the nation’s leading health privacy watchdog. Our mission is to ensure the right to control sensitive health information in electronic health systems, from prescription records to DNA, to protect jobs, reputations, and future opportunities. Patient Privacy Rights has over 12,000 members in all 50 states and leads the bipartis...

ALFRED E. TIEFENBACHER (GmbH & Co. KG)

AET started out in 1963 as a pioneer in the newly developing international active pharmaceutical ingredient business. In a time when there still was no direct telephone service berween the two countries, the Italian based Recordati became the first principal to be represented exclusively in Germany by AET. Today AET has over 40 best-of-breed suppliers from 13 countries around the globe, from which...

Anthera Pharmaceuticals Inc.

Anthera Pharmaceuticals is a privately-held company committed to developing and commercializing clinical pharmaceutical products that address unmet medical needs of patients with life-threatening, chronic and acute inflammatory diseases and autoimmune disorders. The Company has acquired from Eli Lilly and Company and Shionogi & Co.‚ Ltd. worldwide rights (excluding Japan) to a series of clin...

Isler & Pedrazzini AG

It is our goal to become your strategic partner through uniqueness and quality“In order to be successful in today’s economic environment, an enterprise must distinguish itself from its competitors – be unique – and must concentrate on its strengths. This is not only true for you as an entrepreneur, but also for us as counsellors.It is your strength to be ahead of your competitors by provid...

Tigris Pharmaceuticals, Inc

Tigris Pharmaceuticals, Inc. is a venture-backed clinical-stage biopharmaceutical company that commercially develops innovative products for the treatment of important unmet medical needs in cancer and infectious diseases. Tigris is focusing its efforts on the development, testing and commercialization of its lead compound, A-007, as a non-invasive treatment for both pre-cancerous HPV-induced lesi...

Viles & Beckman, LLC

Viles & Beckman, LLC takes pride in making corporations accountable for their actions. It was the first law firm in the U.S. to file a class action suit against the manufacturers of the diet drug Fen-Phen. It helped lead the successful effort to recall defective tires in the Ford/Firestone class action and has been featured on CNN, MSNBC, Good Morning America and CBS Evening News. They have als...

Pacific Legal Foundation

Donor-supported Pacific Legal Foundation is a watchdog organization that litigates for limited government, property rights, individual rights, and free enterprise, in courts nationwide.

Probably Relevant

Miner, Barnhill & Galland, P.C.

Founded in 1971, MBG represents a broad range of individual, government, non-profit and corporate clients with offices in Chicago, Ill., and Madison, Wis. The firm is nationally known for its class action practice in civil rights, employment rights, voting rights, predatory lending, and more, as well as for complex litigation against government fraud. Its ...

Acquire Automation

ORTHOCON, Inc.

ORTHOCON is an innovation driven company committed to developing and commercializing a growing portfolio of novel intraoperative implant devices for the local delivery of therapeutics to bone. ORTHOCON wholly owns its technology platform with exclusive rights to develop and commercialize its products in all countries worldwide.

GeneMedix plc

Founded through a collaboration and joint venture with the Shanghai Institute of Biochemistry, GeneMedix sponsored research and subsequently acquired rights to the manufacture and sale of specified biopharmaceutical proteins using recombinant DNA technology. Our collaboration with the Institute gives GeneMedix worldwide rights to a range of high expression cell lines; an initial portfolio of six m...

Mesoblast Limited

Mesoblast Limited (ASX: MSB; USADR: MBLTY) is a world leader in commercializing biologic products for the broad field of regenerative medicine. Mesoblast has the worldwide exclusive rights for a series of patents and technologies developed over more than 10 years relating to the identification, extraction, culture and uses of adult Mesenchymal Precursor Cells (MPCs). www.mesoblast.com

Immune Network Ltd.

We are not a traditional biotech company. Industries such as high tech and real estate have their merchant developers - organizations who recognize the potential of an idea or property. They analyze market potential, existing infrastructure and current problems, acquire the project and take it forward to the point of re-sale to another developer or final market. That's what we're doing in the biop...

Bounce Innovation Hub and Acquire Investments and JumpStart Inc.

https://bouncehub.org/

ViRexx Medical

ViRexx Medical Corp. is an Edmonton, Alberta based biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and chronic viral infections. ViRexx's most advanced programs include drug candidates for the treatment of ovarian cancer, chronic Hepatitis B & C and solid tumors. The lead product from the AIT™ platform is OvaRex® MAb, a therapy for lat...

GenoVision Inc

GenoVision is an innovative biotechnology company with extensive expertise in HLA/tissue typing ranging from sample preparation to advanced analysis. The GenoVision Group was founded in 1998 and acquired by Qiagen in June 2002. Qiagen has incorporated the nucleic acid technologies and products of GenoVision into their own organization and GenoVision is a stand-alone company with focus o...

Banner & Witcoff, Ltd

Banner & Witcoff, Ltd. is dedicated to excellence in the specialized practice of intellectual property law, including patent, trademark, copyright, trade secret, computer, franchise and unfair competition law. The firm actively engages in the procurement, enforcement and litigation of intellectual property rights throughout the world, including all federal and state agencies, and the distribution ...

Merganser Biotech Inc.

Merganser Biotech was founded by Brian MacDonald and Gene Merutka and is focused on the evaluation of novel hepcidin mimetic peptides for the treatment of beta thalassemia and other rare hematological and iron overload diseases. In 2013 the company obtained an exclusive worldwide license to patent rights for this technology from the Regents of the Universi...

Bryn Aarflot AS (BAA)

Bryn Aarflot AS (BAA) is a privately owned consulting firm, providing assistance to inventors, companies and other intellectual property right owners within all areas of intellectual property law.BAA offers technical and legal assistance on all levels and in all areas relating to intellectual property rights, i.e. all issues relating to patents, trademarks, designs, copyrights, domain names, and m...


More From BioPortfolio on "RECORDATI ACQUIRE WORLDWIDE RIGHTS SIGNIFOR OSILODROSTAT LCI699"

Quick Search

Corporate Database Quicklinks